Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Houssem Benlalam

Showing results (11-20 of 19) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 19 results.
Journal of Molecular Medicine (Berlin, Germany)|April 13, 2010
The anti-angiogenic activity of IL-12 is increased in iNOS-/- mice and involves NK cellsAleksandra Bielawska-Pohl, Séverine Blesson, Houssem Benlalam, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 14, 2011
Hypoxia-dependent inhibition of tumor cell susceptibility to CTL-mediated lysis involves NANOG induction in target cellsMeriem Hasmim, Muhammad Zaeem Noman, Jessica Lauriol, et al.
Cancer Research|December 3, 2008
ICAM-1 has a critical role in the regulation of metastatic melanoma tumor susceptibility to CTL lysis by interfering with PI3K/AKT pathwayAhmed Hamaï, Franck Meslin, Houssem Benlalam, et al.
Cellular Immunology|September 2, 2019
Viral and tumor antigen-specific CD8 T-cell responses in Merkel cell carcinomaMahtab Samimi, Houssem Benlalam, Pascal Aumond, et al.
Oncoimmunology|January 27, 2017
CD40L confers helper functions to human intra-melanoma class-I-restricted CD4<sup>+</sup>CD8<sup>+</sup> double positive T cellsTiphaine Parrot, Romain Oger, Houssem Benlalam, et al.
Oncoimmunology|March 17, 2022
Targeting NKG2A to boost anti-tumor CD8 T-cell responses in human colorectal cancerKathleen Ducoin, Romain Oger, Linda Bilonda Mutala, et al.
European Journal of Immunology|April 21, 2016
IL-9 promotes the survival and function of human melanoma-infiltrating CD4(+) CD8(+) double-positive T cellsTiphaine Parrot, Mathilde Allard, Romain Oger, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 24, 2009
Gap junction communication between autologous endothelial and tumor cells induce cross-recognition and elimination by specific CTLHoussem Benlalam, Abdelali Jalil, Meriem Hasmim, et al.
Cancer Immunology Research|June 4, 2017
Shifting the Balance of Activating and Inhibitory Natural Killer Receptor Ligands on <i>BRAF</i><sup>V600E</sup> Melanoma Lines with VemurafenibAlexandra Frazao, Marina Colombo, Emmanuelle Fourmentraux-Neves, et al.
Pageof 2

Showing results (11-20 of 19) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
Journal of Molecular Medicine (Berlin, Germany)|April 13, 2010
The anti-angiogenic activity of IL-12 is increased in iNOS-/- mice and involves NK cellsAleksandra Bielawska-Pohl, Séverine Blesson, Houssem Benlalam, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 14, 2011
Hypoxia-dependent inhibition of tumor cell susceptibility to CTL-mediated lysis involves NANOG induction in target cellsMeriem Hasmim, Muhammad Zaeem Noman, Jessica Lauriol, et al.
Cancer Research|December 3, 2008
ICAM-1 has a critical role in the regulation of metastatic melanoma tumor susceptibility to CTL lysis by interfering with PI3K/AKT pathwayAhmed Hamaï, Franck Meslin, Houssem Benlalam, et al.
Cellular Immunology|September 2, 2019
Viral and tumor antigen-specific CD8 T-cell responses in Merkel cell carcinomaMahtab Samimi, Houssem Benlalam, Pascal Aumond, et al.
Oncoimmunology|January 27, 2017
CD40L confers helper functions to human intra-melanoma class-I-restricted CD4<sup>+</sup>CD8<sup>+</sup> double positive T cellsTiphaine Parrot, Romain Oger, Houssem Benlalam, et al.
Oncoimmunology|March 17, 2022
Targeting NKG2A to boost anti-tumor CD8 T-cell responses in human colorectal cancerKathleen Ducoin, Romain Oger, Linda Bilonda Mutala, et al.
European Journal of Immunology|April 21, 2016
IL-9 promotes the survival and function of human melanoma-infiltrating CD4(+) CD8(+) double-positive T cellsTiphaine Parrot, Mathilde Allard, Romain Oger, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 24, 2009
Gap junction communication between autologous endothelial and tumor cells induce cross-recognition and elimination by specific CTLHoussem Benlalam, Abdelali Jalil, Meriem Hasmim, et al.
Cancer Immunology Research|June 4, 2017
Shifting the Balance of Activating and Inhibitory Natural Killer Receptor Ligands on <i>BRAF</i><sup>V600E</sup> Melanoma Lines with VemurafenibAlexandra Frazao, Marina Colombo, Emmanuelle Fourmentraux-Neves, et al.
Pageof 2